Lodenosine
Lodenosine is an active compound.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 110143-10-7
- Formule: C10H12FN5O2
- Masse moléculaire:253.23
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| C3H/3T3 | EC50 |
>50 μM
Compound: 2
|
Effect of compound against Moloney murine sarcoma virus (MSV)-induced transformation of C3H/3T3 embryo murine fibroblasts
Effect of compound against Moloney murine sarcoma virus (MSV)-induced transformation of C3H/3T3 embryo murine fibroblasts
|
[PMID: 10229630] |
| CCRF-CEM | CC50 |
>250 μM
Compound: 2
|
Cytotoxic concentration in Wild Type CEM cells
Cytotoxic concentration in Wild Type CEM cells
|
[PMID: 10229630] |
| CCRF-CEM | EC50 |
36.7 μM
Compound: 2
|
Antiviral activity evaluated as the ability to inhibit the replication of HIV-1 in human T-lymphocytic cells (CEM)
Antiviral activity evaluated as the ability to inhibit the replication of HIV-1 in human T-lymphocytic cells (CEM)
|
[PMID: 10229630] |
| CCRF-CEM | EC50 |
40 μM
Compound: 2
|
Antiviral activity evaluated as the ability to inhibit the replication of HIV-2 in human T-lymphocytic cells (CEM)
Antiviral activity evaluated as the ability to inhibit the replication of HIV-2 in human T-lymphocytic cells (CEM)
|
[PMID: 10229630] |
| CCRF-CEM | IC50 |
>100 μM
Compound: 15
|
Cytotoxicity in CEM cells
Cytotoxicity in CEM cells
|
10.1016/0960-894X(95)00133-E |
| H9 | EC50 |
1.16 μM
Compound: beta-FddA
|
Antiviral activity against HIV1 3B in human H9 cells assessed as inhibition of virus-induced cytopathic effect by formazan-based conventional colorimetric technique
Antiviral activity against HIV1 3B in human H9 cells assessed as inhibition of virus-induced cytopathic effect by formazan-based conventional colorimetric technique
|
[PMID: 11430019] |
| H9 | EC50 |
1.16 μM
Compound: beta-FddA
|
Antiviral activity against HIV1 RF in human H9 cells assessed as inhibition of virus-induced cytopathic effect by formazan-based conventional colorimetric technique
Antiviral activity against HIV1 RF in human H9 cells assessed as inhibition of virus-induced cytopathic effect by formazan-based conventional colorimetric technique
|
[PMID: 11430019] |
| HepG2 2.2.15 | EC50 |
>10 μM
Compound: 15
|
In vitro anti-HBV activity in 2.2.15 cells
In vitro anti-HBV activity in 2.2.15 cells
|
10.1016/0960-894X(95)00133-E |
| HepG2 2.2.15 | IC50 |
>200 μM
Compound: 15
|
Cytotoxicity in 2.2.15 cells
Cytotoxicity in 2.2.15 cells
|
10.1016/0960-894X(95)00133-E |
| MT4 | ED50 |
35 μM
Compound: 11
|
Anti-HIV activity was determined as dose required to protect 50% of the HIV-infected MT-4 cells against destruction
Anti-HIV activity was determined as dose required to protect 50% of the HIV-infected MT-4 cells against destruction
|
[PMID: 3499515] |
| Vero | IC50 |
>100 μM
Compound: 15
|
Cytotoxicity in Vero cells
Cytotoxicity in Vero cells
|
10.1016/0960-894X(95)00133-E |
Chemical Information
-
CAS No. 110143-10-7
-
Masse moléculaire 253.23
-
Formule C10H12FN5O2
-
SMILES
F[C@@H]1[C@@H](O[C@@H](C1)CO)N2C3=NC=NC(N)=C3N=C2
-
Synonyms
NSC 613792; F-ddA
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)